Evidence map›Paper›PMID 28887431›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2017

Neutrophil-Derived Cytosolic PLA2α Contributes to Bacterial-Induced Neutrophil Transepithelial Migration.

Lael M Yonker, Michael A Pazos, Bernard B Lanter, Hongmei Mou, Kengyeh K Chu, Alexander D Eaton, Joseph V Bonventre, Guillermo J Tearney, Jayaraj Rajagopal, Bryan P Hurley

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. cPLAScience advances · 2026
    Article
  2. Article
  3. Review
  4. The principles of directed cell migration.Nature reviews. Molecular cell biology · 2021
    Review
  5. The Known Unknowns of the Immune Response toJournal of fungi (Basel, Switzerland) · 2021
    Review
  6. Review
  7. Article
  8. Challenging the evidence for hepoxilin AAmerican journal of physiology. Lung cellular and molecular physiology · 2020
    Article
  9. Cytosolic phospholipase AScientific reports · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Lael M YonkerMucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston, MA 02114.ORCID 0000-0003-1711-8227
Michael A PazosMucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston, MA 02114.
Bernard B LanterMucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston, MA 02114.ORCID 0000-0001-7723-9405
Hongmei MouMucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston, MA 02114.
Kengyeh K ChuWellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114.
Alexander D EatonMucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston, MA 02114.
Joseph V BonventreDepartment of Medicine, Harvard Medical School, Boston, MA 02115.
Guillermo J TearneyWellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA 02114.
Jayaraj RajagopalCenter for Regenerative Medicine, Massachusetts General Hospital, Boston, MA 02114.
Bryan P HurleyMucosal Immunology and Biology Research Center, Massachusetts General Hospital, Boston, MA 02114; bphurley@mgh.harvard.edu.ORCID 0000-0001-6873-4762
Harvard University · USBrigham and Women's Hospital · USMassachusetts General Hospital · US

Funding

Mechanisms of Ischemic Kidney Injury and RepairR37DK039773 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BONVENTRE, JOSEPH VINCENT · 1993 to 2021
$5.2M
The Role of Hepoxilin A3 in Neutrophil Breach of the Infected Airway MucosaR01AI095338 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI HURLEY, BRYAN P · 2012 to 2022
$5.2M
Intercellular communication and cell regulation in airway epithelial ensembles in regeneration and diseaseR01HL118185 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI RAJAGOPAL, JAYARAJ · 2014 to 2021
$4.2M
Defining the role of Hippo signaling in airway injury repair and remodelingR01HL116756 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI RAJAGOPAL, JAYARAJ · 2013 to 2017
$2.2M
NHLBI NIH HHS R01 HL116756NHLBI NIH HHS R01 HL118185NIAID NIH HHS R01 AI095338NIDDK NIH HHS R37 DK039773
6 · The paper itself

Abstract

Eicosanoids are a group of bioactive lipids that are shown to be important mediators of neutrophilic inflammation; selective targeting of their function confers therapeutic benefit in a number of diseases. Neutrophilic airway diseases, including cystic fibrosis, are characterized by excessive neutrophil infiltration into the airspace. Understanding the role of eicosanoids in this process may reveal novel therapeutic targets. The eicosanoid hepoxilin A3 is a pathogen-elicited epithelial-produced neutrophil chemoattractant that directs transepithelial migration in response to infection. Following hepoxilin A3-driven transepithelial migration, neutrophil chemotaxis is amplified through neutrophil production of a second eicosanoid, leukotriene B4 (LTB4). The rate-limiting step of eicosanoid generation is the liberation of arachidonic acid by phospholipase A2, and the cytosolic phospholipase A2 (cPLA2)α isoform has been specifically shown to direct LTB4 synthesis in certain contexts. Whether cPLA2α is directly responsible for neutrophil synthesis of LTB4 in the context of

Indexed as

Transendothelial and Transepithelial Migration8,11,14-Eicosatrienoic AcidAnimalsAntigens, Human PlateletCell CommunicationCell LineChemotaxisCoculture TechniquesCystic FibrosisCytosolHumansLeukotriene B4MiceNeutrophilsPseudomonas aeruginosaPseudomonas Infections8,11,14-Eicosatrienoic Acid8-hydroxy-11,12-epoxyeicosa-5,9,14-trienoic acidAntigens, Human Platelethuman platelet antigen 1bLeukotriene B4

Identifiers

PMID28887431
PMCPMC5636676
OpenAlexW2752238487

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.